• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活物抑制剂-1、凝血酶-抗凝血酶复合物和凝血酶原片段 F1+2 对 TKA 后静脉血栓栓塞的诊断价值高于 D-二聚体。

Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA.

机构信息

Department of orthopedics, General Hospital of Ningxia Medical University, 804 Shengli street, Xingqing district, Yinchuan, Ningxia 750004, China

Ningxia Medical University, 1160 Shengli street, Xingqing district, Yinchuan, Ningxia 750004, China

出版信息

Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221097383. doi: 10.1177/10760296221097383.

DOI:10.1177/10760296221097383
PMID:35535394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9096184/
Abstract

OBJECTIVE

To investigate the diagnostic values of D-dimer, plasminogen activator inhibitor-1 (PAI-1), thrombin-antithrombin (TAT), and prothrombin fragment F1 + 2 (F1 + 2) for predicting venous thromboembolism (VTE) after total knee arthroplasty (TKA).

METHODS

Ultrasonography and CTPA were performed to diagnose VTE in 252 patients who underwent TKAs. Plasma D-dimer, PAI-1, TAT, and F1 + 2 levels were assessed 1-3 days prior to operation (T1), second hour (T2), first (T3), and third day (T4) after the operation. Receiver-operating characteristic curves (ROC) analysis was conducted and pairwise compared to evaluate the diagnostic value of those biomarkers.

RESULTS

Plasma D-dimer levels differed between patients with and without VTE significantly on T4, PAI-1, TAT, and F1 + 2 levels differed on T3 and T4. The areas under ROC of D-dimer, PAI-1, TAT and F1 + 2 levels were 0.645, 0.773, 0.771 and 0.797, respectively. The most feasible cutoff values of D-dimer, PAI-1, TAT and F1 + 2 in predicting VTE after TKA were 2.24 ug/ml, 35.96 ng/ml, 13.36 ng/mg and 11.1 ng/ml, respectively. Pairwise comparison of ROC curves revealed that D-dimer level had the lowest diagnostic accuracy, whereas PAI-1, TAT and F1 + 2 level had similar diagnostic accuracy. There were significant differences in duration of tourniquet time and duration of anesthesia between patients with and without VTE.

CONCLUSION

After TKA, using 2.24ug/mL as the threshold value of D-dimer is more accurate than using 0.5ug/mL in the monitoring of VTE, PAI-1, TAT and F1 + 2 are more valuable than D-dimer in predicting VTE. Duration of tourniquet and duration of anesthesia are risk factors for the development of VTE.

摘要

目的

探讨 D-二聚体、纤溶酶原激活物抑制剂-1(PAI-1)、凝血酶-抗凝血酶(TAT)和凝血酶原片段 F1+2(F1+2)对预测全膝关节置换术后静脉血栓栓塞症(VTE)的诊断价值。

方法

对 252 例行 TKA 的患者进行超声和 CTPA 诊断 VTE。在术前 1-3 天(T1)、术后第 2 小时(T2)、第 1 天(T3)和第 3 天(T4)评估血浆 D-二聚体、PAI-1、TAT 和 F1+2 水平。通过接受者操作特征曲线(ROC)分析并进行两两比较,评估这些生物标志物的诊断价值。

结果

T4 时 VTE 患者与无 VTE 患者的血浆 D-二聚体水平有显著差异,PAI-1、TAT 和 F1+2 水平在 T3 和 T4 时也有显著差异。D-二聚体、PAI-1、TAT 和 F1+2 水平的 ROC 曲线下面积分别为 0.645、0.773、0.771 和 0.797。D-二聚体、PAI-1、TAT 和 F1+2 预测 TKA 后 VTE 的最佳截断值分别为 2.24μg/ml、35.96ng/ml、13.36ng/mg 和 11.1ng/ml。ROC 曲线的两两比较显示,D-二聚体水平的诊断准确性最低,而 PAI-1、TAT 和 F1+2 水平的诊断准确性相似。有 VTE 和无 VTE 患者的止血带时间和麻醉时间存在显著差异。

结论

TKA 后,使用 2.24μg/ml 作为 D-二聚体的阈值比使用 0.5μg/ml 监测 VTE 更准确,PAI-1、TAT 和 F1+2 比 D-二聚体更能预测 VTE。止血带时间和麻醉时间是 VTE 发生的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b856/9096184/7cacef892820/10.1177_10760296221097383-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b856/9096184/39b87b61fae1/10.1177_10760296221097383-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b856/9096184/52b4d3651810/10.1177_10760296221097383-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b856/9096184/25c13120e6b0/10.1177_10760296221097383-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b856/9096184/abab4fe96dc4/10.1177_10760296221097383-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b856/9096184/7cacef892820/10.1177_10760296221097383-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b856/9096184/39b87b61fae1/10.1177_10760296221097383-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b856/9096184/52b4d3651810/10.1177_10760296221097383-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b856/9096184/25c13120e6b0/10.1177_10760296221097383-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b856/9096184/abab4fe96dc4/10.1177_10760296221097383-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b856/9096184/7cacef892820/10.1177_10760296221097383-fig5.jpg

相似文献

1
Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA.纤溶酶原激活物抑制剂-1、凝血酶-抗凝血酶复合物和凝血酶原片段 F1+2 对 TKA 后静脉血栓栓塞的诊断价值高于 D-二聚体。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221097383. doi: 10.1177/10760296221097383.
2
Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.凝血酶-抗凝血酶复合物、纤溶酶-α2纤溶酶抑制物复合物、血栓调节蛋白及纤溶酶原激活物抑制物-1在恶性肿瘤合并静脉血栓患者中的诊断及预后价值
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620971041. doi: 10.1177/1076029620971041.
3
Clinical Impact of Coagulation and Fibrinolysis Markers for Predicting Postoperative Venous Thromboembolism in Total Joint Arthroplasty Patients.凝血和纤溶标志物对预测全关节置换术后静脉血栓栓塞的临床影响。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619877458. doi: 10.1177/1076029619877458.
4
Association between venous thromboembolism and plasma levels of both soluble fibrin and plasminogen-activator inhibitor 1 in 170 patients undergoing total hip arthroplasty.170 例行全髋关节置换术患者中静脉血栓栓塞与可溶性纤维蛋白和纤溶酶原激活物抑制剂 1 血浆水平的相关性。
Acta Orthop. 2012 Feb;83(1):14-21. doi: 10.3109/17453674.2011.652886. Epub 2012 Jan 17.
5
Thrombin-antithrombin III complex tests.凝血酶-抗凝血酶III复合物检测
J Orthop Surg (Hong Kong). 2017 Jan 1;25(1):170840616684501. doi: 10.1177/0170840616684501.
6
Prospective, randomised, controlled study on the efficacy and safety of different strategies of tranexamic acid with total blood loss, blood transfusion rate and thrombogenic biomarkers in total knee arthroplasty: study protocol.前瞻性、随机、对照研究不同氨甲环酸策略在全膝关节置换术中的疗效和安全性与总失血量、输血率和血栓形成生物标志物的关系:研究方案。
BMJ Open. 2021 Feb 26;11(2):e038399. doi: 10.1136/bmjopen-2020-038399.
7
Thrombin antithrombin complex concentration as an early predictor of deep vein thrombosis after total hip arthroplasty and total knee arthroplasty.凝血酶-抗凝血酶复合物浓度作为全髋关节置换术和全膝关节置换术后深静脉血栓形成的早期预测指标。
BMC Musculoskelet Disord. 2022 Jun 14;23(1):574. doi: 10.1186/s12891-022-05532-1.
8
Associations between venous thromboembolism onset, D-dimer, and soluble fibrin monomer complex after total knee arthroplasty.全膝关节置换术后静脉血栓栓塞症发病、D-二聚体与可溶性纤维蛋白单体复合物之间的关联
J Orthop Surg Res. 2015 Nov 10;10:172. doi: 10.1186/s13018-015-0315-4.
9
Plasma D-dimer is not useful in the prediction of deep vein thrombosis after total knee arthroplasty in patients using rivaroxaban for thromboprophylaxis.在使用利伐沙班进行血栓预防的患者中,血浆 D-二聚体对于全膝关节置换术后深静脉血栓的预测没有帮助。
J Orthop Surg Res. 2018 Jul 11;13(1):173. doi: 10.1186/s13018-018-0883-1.
10
Performance of C-Reactive Protein, Procalcitonin, TAT Complex, and Factor VIII in Addition to D-Dimer in the Exclusion of Venous Thromboembolism in Primary Care Patients.除D-二聚体检测外,C反应蛋白、降钙素原、凝血酶-抗凝血酶复合物及凝血因子VIII在基层医疗患者静脉血栓栓塞症排除诊断中的性能评估
J Appl Lab Med. 2022 Mar 2;7(2):444-455. doi: 10.1093/jalm/jfab094.

引用本文的文献

1
Biomarkers in Venous Thrombosis: Diagnostic Potential and Limitations.静脉血栓形成中的生物标志物:诊断潜力与局限性
Biology (Basel). 2025 Jul 1;14(7):800. doi: 10.3390/biology14070800.
2
Caprini score combined with thrombotic molecular markers for predicting DVT in patients with traumatic fractures.Caprini评分联合血栓形成分子标志物用于预测创伤性骨折患者的深静脉血栓形成
Sci Rep. 2025 Jan 13;15(1):1847. doi: 10.1038/s41598-025-85941-z.
3
Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study.

本文引用的文献

1
Correlation between rs1799889 polymorphism and venous thromboembolism: A meta-analysis of 48 case-control studies.rs1799889 多态性与静脉血栓栓塞的相关性:48 项病例对照研究的荟萃分析。
Phlebology. 2020 Aug;35(7):472-479. doi: 10.1177/0268355519897552. Epub 2020 Jan 16.
2
Serum D-Dimer in the Diagnosis of Periprosthetic Knee Infection: Where Are We Today?血清D-二聚体在人工膝关节周围感染诊断中的应用:我们如今进展如何?
J Knee Surg. 2020 Feb;33(2):106-110. doi: 10.1055/s-0039-1698467. Epub 2019 Oct 21.
3
What are the incidence and risk factors of in-hospital mortality after venous thromboembolism events in total hip and knee arthroplasty patients?
有效抗风湿治疗可恢复早期类风湿关节炎患者受损的凝血参数:一项前瞻性试点研究。
RMD Open. 2024 Dec 31;10(4):e004838. doi: 10.1136/rmdopen-2024-004838.
4
Establishing Expectancy Values for Fibrin Monomer in Uncomplicated Pregnancy.建立正常妊娠中纤维蛋白单体的预期值。
TH Open. 2024 Jul 11;8(3):e283-e296. doi: 10.1055/s-0044-1788281. eCollection 2024 Jul.
5
Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?斑秃患者静脉血栓栓塞风险标志物:有什么需要担心的吗?
Dermatol Ther (Heidelb). 2023 Aug;13(8):1847-1855. doi: 10.1007/s13555-023-00971-7. Epub 2023 Jul 9.
6
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism.纤溶酶原激活物抑制剂-1 4G/5G多态性对中国静脉血栓栓塞症患者的临床影响
Thromb J. 2022 Nov 14;20(1):68. doi: 10.1186/s12959-022-00430-x.
全髋关节和膝关节置换术患者发生静脉血栓栓塞事件后院内死亡的发生率及危险因素有哪些?
Arthroplast Today. 2018 May 26;4(3):343-347. doi: 10.1016/j.artd.2018.02.014. eCollection 2018 Sep.
4
Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.全髋关节和膝关节置换术后深静脉血栓形成预防和深静脉血栓形成发生率的趋势。
J Am Acad Orthop Surg. 2018 Oct 1;26(19):698-705. doi: 10.5435/JAAOS-D-17-00235.
5
Natural progress of D-dimer following total joint arthroplasty: a baseline for the diagnosis of the early postoperative infection.全关节置换术后D-二聚体的自然进展:术后早期感染诊断的基线
J Orthop Surg Res. 2018 Feb 13;13(1):36. doi: 10.1186/s13018-018-0730-4.
6
Venous Thromboembolism Prophylaxis in Total Hip Arthroplasty and Total Knee Arthroplasty Patients: From Guidelines to Practice.全髋关节置换术和全膝关节置换术患者的静脉血栓栓塞预防:从指南到实践。
J Am Acad Orthop Surg. 2017 Dec;25(12):789-798. doi: 10.5435/JAAOS-D-15-00760.
7
Changes in Markers of Thrombin Generation and Interleukin-6 During Unicondylar Knee and Total Knee Arthroplasty.在单髁膝关节置换术和全膝关节置换术中凝血酶生成和白细胞介素-6标志物的变化。
J Arthroplasty. 2018 Mar;33(3):684-687. doi: 10.1016/j.arth.2017.10.016. Epub 2017 Oct 16.
8
Changes in blood coagulation-fibrinolysis markers by pneumatic tourniquet during total knee joint arthroplasty with venous thromboembolism.全膝关节置换术中使用气压止血带时血液凝血-纤溶标志物的变化与静脉血栓栓塞
J Arthroplasty. 2014 Mar;29(3):569-73. doi: 10.1016/j.arth.2013.08.011. Epub 2013 Nov 28.
9
Diagnosis of deep venous thrombosis and pulmonary embolism.深静脉血栓形成和肺栓塞的诊断。
Am Fam Physician. 2012 Nov 15;86(10):913-9.
10
American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty.美国矫形外科医师学会关于择期髋关节和膝关节置换术患者预防静脉血栓栓塞性疾病的临床实践指南。
J Bone Joint Surg Am. 2012 Apr 18;94(8):746-7. doi: 10.2106/JBJS.9408.ebo746.